Octreotide scanning for carcinoid tumours.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9338023.
- Also identified by PMC identifier 2431390.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The somatostatin analogue octreotide may be used in the diagnosis of carcinoid and other neuroendocrine tumours. Radionuclide scanning following intravenous injection of 111Indium-labelled octreotide (111In-DTPA-pentetreotide) provides a sensitive, non-invasive method of localising somatostatin-positive tumours. The technique may also be used to identify patients who may respond to 'cold' octreotide therapy and to monitor therapeutic efficacy.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Carcinoid Tumor
- Indium Radioisotopes
- Octreotide